You must have one of these extentions in you browser

AdBlock, AdBlock Plus, uBlock Origin or others
  1. Go to your browser extentions and click the Ad blocker icon
  2. Select pause on this site, don't run on pages on this site, or some other similar option.
  3. Now you can refresh the page

MedCommopen access

United States |Universities and research institutions |Media Ranking

Country

Universities and research institutions Media Ranking

Subject Area and Category

Publisher

John Wiley and Sons Inc

SJR 2024

2.469 Q1

H-Index

41

Publication type

Journals

ISSN

26882663

Coverage

2020-2025

Information

Home
How to publish in this journal
[email protected]

Scope

MedComm is interested in topics including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology and artificial intelligence. The journal focuses on clinical and experimental advances on disease characteristics, pathogenic mechanism and medical techniques. Topics of interest include, but are not limited to: • Epigenetics, genomics, proteomics and metabonomics • Non-coding RNA in disease • Cell senescence and cell death • Cellular signal transduction • Gene therapy and gene editing • Cancer immunology and immunotherapy • Structural biology, chemical genomics and drug discovery • High-definition imaging • Artificial intelligence in medicine • Stem cells and regenerative medicine • Nanomedicine and drug delivery system • Early disease diagnosis and biomarkers • Clinical trials evaluating new treatments for cancer or other diseases

Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Biochemistry (medical)2023Q1
Biochemistry (medical)2024Q1
Cell Biology2023Q1
Cell Biology2024Q1
Drug Discovery2023Q1
Drug Discovery2024Q1
Genetics2023Q1
Genetics2024Q1
Genetics (clinical)2023Q1
Genetics (clinical)2024Q1
Immunology and Allergy2023Q1
Immunology and Allergy2024Q1
Oncology2023Q1
Oncology2024Q1
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20231.926
20242.469
Total Documents

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

YearDocuments
202038
202150
202282
2023245
2024342
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20200
External Cites per document20212.342
External Cites per document20227.830
External Cites per document20237.953
External Cites per document20249.032
Cites per document20200.000
Cites per document20212.395
Cites per document20227.955
Cites per document20238.241
Cites per document20249.284
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
202031.58
202134.00
202234.15
202315.51
202419.30
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20200
Uncited documents202114
Uncited documents202211
Uncited documents202323
Uncited documents202460
Cited documents20200
Cited documents202124
Cited documents202277
Cited documents2023147
Cited documents2024317
% Female Authors

Evolution of the percentage of female authors.

YearFemale Percent
202034.83
202143.64
202242.13
202342.31
202444.38
Estimated APC

It estimates the article processing charges (APCs) a journal might charge, based on its visibility, prestige, and impact as measured by the SJR. It does not reflect the actual APC, but rather a calculated approximation based on journal quality.

YearEst. APC (USD)
2020
2021
2022
20233757
20243849
Estimated financial value

It represents the potential financial worth of a journal. It is obtained by multiplying the journal's Estimated APC by the total number of citable documents published over the past five years. This value reflects the hypothetical revenue a journal could generate based on its estimated publication costs and scholarly output.

YearEst. value (USD)
2020
2021
2022
2023920442
20242259590
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20200
Self Cites20212
Self Cites202211
Self Cites202349
Self Cites202495
Total Cites20200
Total Cites202191
Total Cites2022700
Total Cites20231401
Total Cites20243500
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20200.000
Cites / Doc. (4 years)20212.395
Cites / Doc. (4 years)20227.955
Cites / Doc. (4 years)20238.241
Cites / Doc. (4 years)20248.800
Cites / Doc. (3 years)20200.000
Cites / Doc. (3 years)20212.395
Cites / Doc. (3 years)20227.955
Cites / Doc. (3 years)20238.241
Cites / Doc. (3 years)20249.284
Cites / Doc. (2 years)20200.000
Cites / Doc. (2 years)20212.395
Cites / Doc. (2 years)20227.955
Cites / Doc. (2 years)20239.227
Cites / Doc. (2 years)20248.572
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20200
Non-citable documents20219
Non-citable documents202214
Non-citable documents202326
Non-citable documents202450
Citable documents20200
Citable documents202129
Citable documents202274
Citable documents2023144
Citable documents2024327
Documents cited by public policy (Overton)

Evolution of the number of documents cited by public policy documents according to Overton database.

DocumentsYearValue
Overton20201
Overton20214
Overton20223
Overton20230
Overton20240
Documents related to SDGs (UN)

Evolution of the number of documents related to Sustainable Development Goals defined by United Nations. Available from 2018 onwards.

DocumentsYearValue
SDG202030
SDG202140
SDG202259
SDG2023146
SDG2024228
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code: "SCImago" size="25" />
SCImago graphica SCImago Graphica

Explore, visually communicate and make sense of data with our new data visualization tool.
Loading comments…

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

SCImago Journal & Country Rank

Services

About us

SCImago’s products

Powered by:
Scopus®
© 2025 SCImago Journal & Country Rank
Legal Notice Privacy Policy